Heart-type fatty acid-binding protein was measured at rest and under stress in 2,690 patients assessed for coronary disease that restricts blood flow, present in 34%. The marker separated those with the disease from those without only slightly better than chance, with an area under the curve of 0.561. Over eight years, all-cause mortality rose from 7.7% in the lowest quartile of the marker to 44% in the highest.
Why it is interesting: A marker proposed for detecting coronary disease identified who later died rather than who had it.
Abstract — the authors' own words, CC BY
Background
This study aimed to evaluate the diagnostic and prognostic utility of heart-type fatty acid-binding protein (H-FABP) in patients with suspected functionally relevant coronary artery disease (fCAD). Methods
The presence of fCAD was centrally adjudicated using myocardial perfusion imaging and coronary angiography. H-FABP high-sensitivity cardiac troponin T (hs-cTnT), and high-sensitivity cardiac troponin I (hs-cTnI) concentrations were measured at rest, peak stress, and 2 h after stress in a blinded fashion.Centrally adjudicated outcomes included all-cause death and cardiovascular death during 8-years. Results
Among 2690 patients included in the diagnostic analysis (median age 68 years, 32% women), fCAD was present in 924 individuals (34%). Baseline H-FABP concentrations were higher in patients with fCAD than in those without (29 [23-38] vs 27 [22-35] ng/mL, p Conclusions
H-FABP demonstrated limited diagnostic accuracy for detecting fCAD but is strongly and independently associated with long-term mortality.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.